At the news
? NEUTRALIMPACT 2/10 SC 13G/A filed Nov 16, 2026 at 10:00 ET
T. Rowe Price Associates filed an amended Schedule 13G disclosing a 5.1% passive stake in Viatris as of September 30, 2026, down from 6.3% in the prior filing 10 days ago. The reduction is modest and consistent with routine portfolio rebalancing by a passive investment manager.
- T. Rowe Price Associates reported beneficial ownership of 58,912,075 shares of Viatris common stock as of September 30, 2026.
- The stake represents 5.1% of shares outstanding, down from 6.3% in the prior SC 13G/A filed November 6, 2026.
- The filing is a passive investor update under Rule 13d-1(b); T. Rowe Price disclaims beneficial ownership and intent to influence control.
- The reduction of approximately 1.2 percentage points is within normal range for a passive manager's portfolio adjustments.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access